Gilead Won’t Give Up Easily On Viread Patent Battle In China
This article was originally published in PharmAsia News
Executive Summary
China’s State Intellectual Property Office announced the invalidation of a patent for Viread, which is manufactured by Gilead and distributed by GSK in China. However, Gilead still holds several patents to protect the drug in China.